Biokine – BioLineRx Presents Top-Line Results from Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer at ESMO 2018 Congress – CBI
Homepage /  Press Release /  Biokine – BioLineRx Presents Top-Line Results from Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer at ESMO 2018 Congress

Press Release

Biokine – BioLineRx Presents Top-Line Results from Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer at ESMO 2018 Congress